Work

A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy

Year: 1993

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v82.9.2624.2624

Authors: PL Amlot, MJ Stone, D Cunningham, J Fay, J Newman, R Collins, R May, M McCarthy, J Richardson, V Ghetie

Institution: The Royal Free Hospital

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G76924547, IMMUNOTOXIN THERAPY FOR B CELL TUMORS

OpenAlex ID: W2364870605

FWCI: 5.753

Cites: 21

Cited by: 235

Related to: 9